nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—SLC5A11—NRF2 pathway—ADH7—pharynx cancer	0.0583	0.0588	CbGpPWpGaD
Dapagliflozin—SLC5A4—NRF2 pathway—ADH7—pharynx cancer	0.0426	0.0429	CbGpPWpGaD
Dapagliflozin—CYP2A6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0417	0.042	CbGpPWpGaD
Dapagliflozin—UGT2B4—Phase II conjugation—CNDP2—pharynx cancer	0.0413	0.0416	CbGpPWpGaD
Dapagliflozin—CYP2A6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0365	0.0368	CbGpPWpGaD
Dapagliflozin—SLC5A2—NRF2 pathway—ADH7—pharynx cancer	0.0322	0.0325	CbGpPWpGaD
Dapagliflozin—SLC5A1—NRF2 pathway—ADH7—pharynx cancer	0.0322	0.0325	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.031	0.0313	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0272	0.0275	CbGpPWpGaD
Dapagliflozin—UGT2B4—Biological oxidations—CNDP2—pharynx cancer	0.0241	0.0244	CbGpPWpGaD
Dapagliflozin—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0234	0.0236	CbGpPWpGaD
Dapagliflozin—SLC5A4—Carbohydrate metabolism—B4GALT5—pharynx cancer	0.0225	0.0227	CbGpPWpGaD
Dapagliflozin—UGT2B4—Biological oxidations—ADH7—pharynx cancer	0.0218	0.022	CbGpPWpGaD
Dapagliflozin—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0205	0.0207	CbGpPWpGaD
Dapagliflozin—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0198	0.02	CbGpPWpGaD
Dapagliflozin—UGT2B4—Biological oxidations—ADH1B—pharynx cancer	0.0191	0.0193	CbGpPWpGaD
Dapagliflozin—UGT2B7—Phase II conjugation—CNDP2—pharynx cancer	0.0188	0.019	CbGpPWpGaD
Dapagliflozin—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0174	0.0175	CbGpPWpGaD
Dapagliflozin—SLC5A2—Carbohydrate metabolism—B4GALT5—pharynx cancer	0.0171	0.0172	CbGpPWpGaD
Dapagliflozin—SLC5A1—Carbohydrate metabolism—B4GALT5—pharynx cancer	0.0171	0.0172	CbGpPWpGaD
Dapagliflozin—UGT1A9—Phase II conjugation—CNDP2—pharynx cancer	0.0153	0.0154	CbGpPWpGaD
Dapagliflozin—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0153	0.0154	CbGpPWpGaD
Dapagliflozin—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0134	0.0135	CbGpPWpGaD
Dapagliflozin—CYP2A6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0117	0.0118	CbGpPWpGaD
Dapagliflozin—UGT2B7—NRF2 pathway—ADH7—pharynx cancer	0.0113	0.0114	CbGpPWpGaD
Dapagliflozin—UGT2B7—Biological oxidations—CNDP2—pharynx cancer	0.011	0.0111	CbGpPWpGaD
Dapagliflozin—CYP2A6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0103	0.0104	CbGpPWpGaD
Dapagliflozin—UGT2B7—Biological oxidations—ADH7—pharynx cancer	0.00995	0.01	CbGpPWpGaD
Dapagliflozin—UGT1A9—NRF2 pathway—ADH7—pharynx cancer	0.00921	0.0093	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—CNDP2—pharynx cancer	0.00894	0.00902	CbGpPWpGaD
Dapagliflozin—CYP1A1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00874	0.00882	CbGpPWpGaD
Dapagliflozin—UGT2B7—Biological oxidations—ADH1B—pharynx cancer	0.00872	0.0088	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—ADH7—pharynx cancer	0.00808	0.00815	CbGpPWpGaD
Dapagliflozin—CYP1A1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00766	0.00773	CbGpPWpGaD
Dapagliflozin—CYP2A6—NRF2 pathway—ADH7—pharynx cancer	0.0071	0.00717	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—ADH1B—pharynx cancer	0.00709	0.00715	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—CNDP2—pharynx cancer	0.00706	0.00712	CbGpPWpGaD
Dapagliflozin—UGT1A9—PPAR Alpha Pathway—CCND1—pharynx cancer	0.00699	0.00705	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—CNDP2—pharynx cancer	0.00689	0.00695	CbGpPWpGaD
Dapagliflozin—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00658	0.00664	CbGpPWpGaD
Dapagliflozin—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00652	0.00658	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—B4GALT5—pharynx cancer	0.00639	0.00644	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—ADH7—pharynx cancer	0.00638	0.00644	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—ADH7—pharynx cancer	0.00623	0.00629	CbGpPWpGaD
Dapagliflozin—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00577	0.00582	CbGpPWpGaD
Dapagliflozin—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00572	0.00577	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—ADH1B—pharynx cancer	0.0056	0.00565	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.00559	0.00564	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00557	0.00562	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—ADH1B—pharynx cancer	0.00546	0.00551	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—B4GALT5—pharynx cancer	0.00535	0.0054	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—CNDP2—pharynx cancer	0.00535	0.0054	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—CNDP2—pharynx cancer	0.00535	0.0054	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—CNDP2—pharynx cancer	0.00513	0.00518	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00489	0.00493	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—B4GALT5—pharynx cancer	0.00484	0.00488	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—B4GALT5—pharynx cancer	0.00484	0.00488	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ADH7—pharynx cancer	0.00484	0.00488	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ADH7—pharynx cancer	0.00484	0.00488	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—ADH7—pharynx cancer	0.00464	0.00468	CbGpPWpGaD
Dapagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0043	0.00434	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ADH1B—pharynx cancer	0.00424	0.00428	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ADH1B—pharynx cancer	0.00424	0.00428	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—CNDP2—pharynx cancer	0.00413	0.00417	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—ADH1B—pharynx cancer	0.00407	0.00411	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—B4GALT5—pharynx cancer	0.00405	0.00409	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—B4GALT5—pharynx cancer	0.00405	0.00409	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00386	0.0039	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.00383	0.00386	CbGpPWpGaD
Dapagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00377	0.0038	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ADH7—pharynx cancer	0.00373	0.00377	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.00349	0.00352	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00347	0.0035	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.00346	0.00349	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ADH1B—pharynx cancer	0.00327	0.0033	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00327	0.0033	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—B4GALT5—pharynx cancer	0.00313	0.00316	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00306	0.00309	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.00304	0.00306	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.00296	0.00299	CbGpPWpGaD
Dapagliflozin—CYP2A6—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00293	0.00296	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.0026	0.00262	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00253	0.00255	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00228	0.0023	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.002	0.00202	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00199	0.00201	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00199	0.00201	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CNDP2—pharynx cancer	0.00188	0.0019	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ADH7—pharynx cancer	0.0017	0.00172	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CNDP2—pharynx cancer	0.00153	0.00154	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ADH1B—pharynx cancer	0.00149	0.0015	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—B4GALT5—pharynx cancer	0.00143	0.00144	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ADH7—pharynx cancer	0.00138	0.00139	CbGpPWpGaD
Dapagliflozin—SLC5A1—parotid gland—pharynx cancer	0.0013	0.149	CbGeAlD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00127	0.00128	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00127	0.00128	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ADH1B—pharynx cancer	0.00121	0.00122	CbGpPWpGaD
Dapagliflozin—SLC5A11—spinal cord—pharynx cancer	0.00119	0.138	CbGeAlD
Dapagliflozin—CYP2A6—Metabolism—CNDP2—pharynx cancer	0.00118	0.00119	CbGpPWpGaD
Dapagliflozin—SLC5A4—head—pharynx cancer	0.00117	0.135	CbGeAlD
Dapagliflozin—UGT1A9—Metabolism—B4GALT5—pharynx cancer	0.00116	0.00117	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—EGFR—pharynx cancer	0.00114	0.00115	CbGpPWpGaD
Dapagliflozin—SLC5A1—epithelium—pharynx cancer	0.00108	0.125	CbGeAlD
Dapagliflozin—CYP2A6—Metabolism—ADH7—pharynx cancer	0.00107	0.00107	CbGpPWpGaD
Dapagliflozin—SLC5A11—head—pharynx cancer	0.00106	0.122	CbGeAlD
Dapagliflozin—SLC5A1—trachea—pharynx cancer	0.000957	0.11	CbGeAlD
Dapagliflozin—CYP2A6—Metabolism—ADH1B—pharynx cancer	0.000934	0.000942	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—B4GALT5—pharynx cancer	0.000893	0.000901	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CNDP2—pharynx cancer	0.000878	0.000886	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—EGFR—pharynx cancer	0.000864	0.000872	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—EGFR—pharynx cancer	0.000864	0.000872	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ADH7—pharynx cancer	0.000794	0.000801	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000701	0.000707	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ADH1B—pharynx cancer	0.000696	0.000702	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—B4GALT5—pharynx cancer	0.000665	0.000671	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000661	0.000666	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.000655	0.000661	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00065	0.000656	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ADH7—pharynx cancer	0.000634	0.00064	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000598	0.000603	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ADH7—pharynx cancer	0.000592	0.000598	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.00056	0.000565	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ADH1B—pharynx cancer	0.000556	0.000561	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000531	0.000536	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000524	0.000529	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.000519	0.000524	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00051	0.000514	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ADH7—pharynx cancer	0.000506	0.000511	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000501	0.000505	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.000496	0.000501	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.000444	0.000448	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000432	0.000436	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000428	0.000432	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000424	0.000428	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000391	0.000394	CbGpPWpGaD
Dapagliflozin—CYP1A1—mouth—pharynx cancer	0.00035	0.0404	CbGeAlD
Dapagliflozin—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000343	0.000346	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000327	0.00033	CbGpPWpGaD
Dapagliflozin—CYP1A1—parotid gland—pharynx cancer	0.000244	0.0281	CbGeAlD
Dapagliflozin—CYP1A1—epithelium—pharynx cancer	0.000204	0.0235	CbGeAlD
Dapagliflozin—CYP1A1—trachea—pharynx cancer	0.00018	0.0208	CbGeAlD
Dapagliflozin—CYP2D6—brainstem—pharynx cancer	0.000165	0.0191	CbGeAlD
Dapagliflozin—CYP1A1—head—pharynx cancer	0.000127	0.0146	CbGeAlD
Dapagliflozin—ABCB1—epithelium—pharynx cancer	0.000106	0.0122	CbGeAlD
Dapagliflozin—ABCB1—trachea—pharynx cancer	9.36e-05	0.0108	CbGeAlD
Dapagliflozin—CYP2D6—head—pharynx cancer	9.13e-05	0.0105	CbGeAlD
Dapagliflozin—CYP1A1—lymph node—pharynx cancer	8.86e-05	0.0102	CbGeAlD
Dapagliflozin—ABCB1—lymphoid tissue—pharynx cancer	8.15e-05	0.0094	CbGeAlD
Dapagliflozin—ABCB1—spinal cord—pharynx cancer	7.39e-05	0.00852	CbGeAlD
Dapagliflozin—ABCB1—head—pharynx cancer	6.57e-05	0.00757	CbGeAlD
Dapagliflozin—ABCB1—lymph node—pharynx cancer	4.6e-05	0.0053	CbGeAlD
